|View printer-friendly version|
|Infinity to Present at the Seventh Annual JMP Securities Healthcare Conference|
A live webcast of Infinity's presentation will be accessible on the “investors/media” section of the company's website, www.infi.com, and will be available for 30 days following the event.
Infinity is an innovative drug discovery and development company seeking to discover, develop and deliver to patients best-in-class medicines for diseases with significant unmet need. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity’s programs focused on the inhibition of heat shock protein 90 and phosphoinositide-3-kinase are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company’s website at www.infi.com.